NON-SURGICAL TREATMENTS FOR BENIGN PROSTATIC HYPERPLASIA

• DOI: 10.22533/at.ed.1592502229084

• Palavras-chave: Prostatic Hyperplasia. Pharmacological Treatment. Men's Health.

• Keywords: Prostatic Hyperplasia. Pharmacological Treatment. Men's Health.

• Abstract:

  Benign Prostatic Hyperplasia (BPH) is the most common benign neoplasm in men and is a process that is closely related to aging, the presence of sex hormones and genetics. The disease may be associated with significant lower urinary tract symptoms, impacting the quality of life and daily activities of affected individuals. The present study aims to briefly discuss non-surgical measures for the treatment of this disease. This is a review made using PubMed, Scielo, Medline and Google Scholar databases, and the keywords were used for research: treatment and benign prostatic hyperplasia. The scientific articles included were published between 2010 and 2022, and those that were available in full, consistent with the topic of the study. Non-surgical treatment has evolved a lot in recent years, and with that, the number of prostate surgeries has been reduced. The proposal for the treatment of Benign Prostatic Hyperplasia is not only to focus on improving the complaints, but also to try to avoid their progression. First-line drugs for the treatment of BPH are α-blockers, which promote relaxation in the ureteral muscles, and 5-α-reductase enzyme inhibitors, which decrease prostate volume. Studies have shown that the combination of the two drugs makes the treatment more beneficial. Other non-surgical therapeutic measures that can be used are phytotherapies and active observation of the disease. Such measures can significantly improve the quality of life of individuals.

• Número de páginas: 6